MYCN/MNX1 Axis Drives NSCLC Progression by Inducing Macrophage M2 Polarization and CD8+ T Cell Apoptosis via the Wnt/β‐Catenin Pathway DOI

Chengzhang Cao,

Hong-Toan Lai,

Shi Yu-zhen

и другие.

Journal of Biochemical and Molecular Toxicology, Год журнала: 2025, Номер 39(4)

Опубликована: Апрель 1, 2025

ABSTRACT Enhanced macrophage M2 polarization and CD8 + T cell dysfunction contribute to the pathophysiology of non‐small lung cancer (NSCLC). Motor neuron pancreatic homeobox 1 (MNX1) has emerged as a potential tumor‐promoting player. Here, we clarified activity MNX1 in NSCLC. PMA‐induced THP‐1 M0‐like macrophages or cells were co‐cultured with NSCLC cells. Cell colony formation, migration, proliferation, apoptosis, invasiveness assessed by wound healing, CCK‐8, flow cytometry, transwell assays, respectively. The ratio CD206 was analyzed cytometry. Ki‐67 expression tested immunofluorescence. ChIP luciferase assays used evaluate relationship between MYCN MNX1. highly expressed NSCLC, its loss‐of‐function suppressed growth, motility, depletion also diminished apoptosis. Mechanistically, increased at transcriptional level. increase reversed impact on malignant behaviors, polarization, viability. vivo growth A549 subcutaneous xenografts. Additionally, counteracted Wnt/β‐catenin pathway. Our findings elucidate oncogenic role MYCN/MNX1/Wnt/β‐catenin pathway driving diminishing study thus uncovers novel mechanism underlying development highlights targets for combating

Язык: Английский

Connecting the Dots: LncRNAs in the KRAS Pathway and Cancer DOI
Mudasir Maqbool, Md Sadique Hussain, Ajay Singh Bisht

и другие.

Pathology - Research and Practice, Год журнала: 2024, Номер 262, С. 155570 - 155570

Опубликована: Авг. 29, 2024

Язык: Английский

Процитировано

10

Exploring the oncogenic and tumor-suppressive roles of Circ-ADAM9 in cancer DOI
Md Sadique Hussain, Ehssan Moglad, Pooja Bansal

и другие.

Pathology - Research and Practice, Год журнала: 2024, Номер 256, С. 155257 - 155257

Опубликована: Март 13, 2024

Язык: Английский

Процитировано

9

Noncoding RNAs in the COVID-19 Saga: An Untold Story DOI
Mudasir Maqbool, Md Sadique Hussain, Nusrat K. Shaikh

и другие.

Viral Immunology, Год журнала: 2024, Номер 37(6), С. 269 - 286

Опубликована: Июль 5, 2024

Язык: Английский

Процитировано

9

PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities DOI
Mohammed Ageeli Hakami, Ali Hazazi, Farhan R. Khan

и другие.

Pathology - Research and Practice, Год журнала: 2023, Номер 253, С. 155019 - 155019

Опубликована: Дек. 7, 2023

Язык: Английский

Процитировано

20

Green Synthesis of Silver Nanoparticles and their Potential Applications in Mitigating Cancer DOI
Reyaz Hassan Mir, Mudasir Maqbool, Prince Ahad Mir

и другие.

Current Pharmaceutical Design, Год журнала: 2024, Номер 30(31), С. 2445 - 2467

Опубликована: Май 10, 2024

In recent years, the field of nanotechnology has brought about significant advancements that have transformed landscape disease diagnosis, prevention, and treatment, particularly in realm medical science. Among various approaches to nanoparticle synthesis, green synthesis method garnered increasing attention. Silver nanoparticles (AgNPs) emerged as noteworthy nanomaterials within spectrum metallic employed for biomedical applications. AgNPs possess several key attributes make them highly valuable field. They are biocompatible, cost-effective, environmentally friendly, rendering suitable bioengineering Notably, found a prominent role domain cancer diagnosis. Research investigations provided evidence AgNPs' anticancer activity, which involves mechanisms such DNA damage, cell cycle arrest, induction apoptosis, regulation specific cytokine genes. The primarily reduction silver ions by reducing agents. Interestingly, natural products living organisms proven be effective sources generation precursor materials used AgNP synthesis. This comprehensive review aims summarize aspects AgNPs, including their characterization, properties, biogenic Furthermore, highlights potential applications these combating cancer.

Язык: Английский

Процитировано

7

Non-Coding RNA: A Key Regulator in the Glutathione-GPX4 Pathway of Ferroptosis DOI Creative Commons
Md Sadique Hussain, Gaurav Gupta, Moyad Shahwan

и другие.

Non-coding RNA Research, Год журнала: 2024, Номер 9(4), С. 1222 - 1234

Опубликована: Май 20, 2024

Ferroptosis, a form of regulated cell death, has emerged as crucial process in diverse pathophysiological states, encompassing cancer, neurodegenerative ailments, and ischemia-reperfusion injury. The glutathione (GSH)-dependent lipid peroxidation pathway, chiefly governed by peroxidase 4 (GPX4), assumes an essential part driving ferroptosis. GPX4, the principal orchestrator ferroptosis, garnered significant attention across cardiovascular, neuroscience domains over past decade. Noteworthy investigations have elucidated indispensable functions ferroptosis numerous diseases, including tumorigenesis, wherein robust within cells can impede tumor advancement. Recent research underscored complex regulatory role non-coding RNAs (ncRNAs) regulating GSH-GPX4 network, thus influencing cellular susceptibility to This exhaustive review endeavors probe into multifaceted processes which ncRNAs control network Specifically, we delve miRNAs, lncRNAs, circRNAs GPX4 expression impacting Moreover, discuss clinical implications dysregulated interactions between several conditions, underscoring their capacity viable targets for therapeutic intervention. Additionally, explores emerging strategies aimed at targeting modulate pathway manipulate advantage. A comprehensive understanding these intricate networks furnishes insights innovative avenues diseases associated with perturbed thereby laying groundwork interventions ferroptosis-related pathological conditions.

Язык: Английский

Процитировано

7

HOTAIR: A key regulator of the Wnt/β-catenin signaling cascade in cancer progression and treatment DOI
Mohammed Ageeli Hakami, Ali Hazazi,

Osama Abdulaziz

и другие.

Pathology - Research and Practice, Год журнала: 2023, Номер 253, С. 154957 - 154957

Опубликована: Ноя. 19, 2023

Язык: Английский

Процитировано

11

Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics DOI
Shivkanya Fuloria,

Geeta Yadav,

Soumya V. Menon

и другие.

Pathology - Research and Practice, Год журнала: 2024, Номер 259, С. 155346 - 155346

Опубликована: Май 11, 2024

Язык: Английский

Процитировано

4

Beyond the Genome: Deciphering the Role of MALAT1 in Breast Cancer Progression DOI
Md Sadique Hussain, Mohit Agrawal, Nusrat K. Shaikh

и другие.

Current Genomics, Год журнала: 2024, Номер 25(5), С. 343 - 357

Опубликована: Май 23, 2024

The MALAT1, a huge non-coding RNA, recently came to light as multifaceted regulator in the intricate landscape of breast cancer (BC) progression. This review explores functions and molecular interactions shedding on its profound implications for understanding BC pathogenesis advancing therapeutic strategies. article commences by acknowledging global impact pressing need insights into underpinnings. It is stated that core lncRNA MALAT1 has range roles both healthy diseased cell functions. this unravels MALAT1's role progression, elucidating participation critical processes like resistance, invasion, relocation, proliferating cells therapy. mechanisms through which modulates gene expression, interacts with other molecules, influences signalling pathways. Furthermore, paper emphasizes clinical significance possible prognostic diagnostic biomarker. Concluding forward-looking note, highlights broader biology, such connections therapy resistance metastasis. underscores deeper investigations these pave way precision medicine approaches. pivotal progression deciphering beyond genome, offering disease potential targeted interventions.

Язык: Английский

Процитировано

4

Harnessing Pyroptosis for Lung Cancer Therapy: The Impact of NLRP3 Inflammasome Activation DOI
Rajiv Dahiya, Vijaykumar Sutariya, Sheeba Varghese Gupta

и другие.

Pathology - Research and Practice, Год журнала: 2024, Номер 260, С. 155444 - 155444

Опубликована: Авг. 1, 2024

Язык: Английский

Процитировано

4